APA (7th ed.) Citation

M, R., JS, L., TV, P., J, V., JC, K., HM, V., . . . CR, J. (2016). Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer. Proteomics. Clinical applications, 10(7), 743. https://doi.org/10.1002/prca.201600025

Chicago Style (17th ed.) Citation

M, Rovithi, Lind JS, Pham TV, Voortman J, Knol JC, Verheul HM, Smit EF, and Jimenez CR. "Response and Toxicity Prediction by MALDI-TOF-MS Serum Peptide Profiling in Patients with Non-small Cell Lung Cancer." Proteomics. Clinical Applications 10, no. 7 (2016): 743. https://doi.org/10.1002/prca.201600025.

MLA (9th ed.) Citation

M, Rovithi, et al. "Response and Toxicity Prediction by MALDI-TOF-MS Serum Peptide Profiling in Patients with Non-small Cell Lung Cancer." Proteomics. Clinical Applications, vol. 10, no. 7, 2016, p. 743, https://doi.org/10.1002/prca.201600025.